TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06275360: Repositioning Immunotherapy in VetArans With Lung Cancer

Sponsor: VA Office of Research and Development · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 25 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$1,524,600

Rescue Site Savings

+$1,016,400

Unlock Full NCT06275360 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06275360 Rescue Dossier →